NCT06717412View on ClinicalTrials.gov

Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy

NARecruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Retinopathy of Prematurity (ROP)
Interventions
DRUG

Conbercept

Administered as an intravitreal injection

Trial Locations (3)

710032

RECRUITING

Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Medical University, Xi'an

RECRUITING

Department of Ophthalmology, Xijing Hospital, Air Force Military Medical University, Xi'an

712000

RECRUITING

Department of Ophthalmology, Xianyang Rainbow Hospital, Xianyang

All Listed Sponsors
lead

Wang Yusheng

OTHER